Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 10/2018

16-06-2018

Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Auteurs: N. E. Carlozzi, S. Schilling, A. L. Kratz, J. S. Paulsen, S. Frank, J. C. Stout

Gepubliceerd in: Quality of Life Research | Uitgave 10/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Symptom progression in Huntington disease (HD) is associated with cognitive decline which may interfere with the self-report of symptoms. Unfortunately, data to support or refute the psychometric reliability of patient-reported outcomes (PROs) as HD progresses are limited. This is problematic given that PROs are increasingly recognized as important measures of efficacy for new treatments.

Methods

We examined PRO data from the HDQLIFE Measurement System (Speech Difficulties; Swallowing Difficulties; Chorea) in 509 individuals with premanifest, early-stage, or late-stage HD. Clinician-administered assessments of motor functioning (items from the UHDRS) and standardized objective assessments of cognition (Stroop, Symbol Digit Modalities) were also collected. We examined item bias using differential item functioning (DIF) across HD stage (premanifest, early-, late-) and relative to cognitive performance. We also examined the correlations between self-report and clinician ratings. Regression models that considered total cognitive ability were utilized to determine psychometric reliability of the PROs.

Results

Most PRO items were free from DIF for both staging and cognition. There were modest correlations between PROs and clinician report (ranged from − 0.40 to − 0.60). Modeling analyses indicated that psychometric reliability breaks down with poorer cognition and more progressed disease stage; split-half reliability was compromised (i.e., split-half reliability < 0.80) when scores were < 136 for Chorea, < 109 for Speech Difficulties, and < 179 for Swallowing Difficulties.

Conclusions

Results indicate that the psychometric reliability of PROs can be compromised as HD symptoms progress and cognition declines. Clinicians should consider PROs in conjunction with other types of assessments when total cognition scores exceed critical thresholds.
Literatuur
1.
go back to reference The Huntington’s Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 1993. 72: 971–983. CrossRef The Huntington’s Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 1993. 72: 971–983. CrossRef
2.
go back to reference Ross, C. A., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204–216. CrossRefPubMed Ross, C. A., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204–216. CrossRefPubMed
3.
go back to reference Squitieri, F., et al.(2015). Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89(3), 367–370. Squitieri, F., et al.(2015). Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89(3), 367–370.
4.
go back to reference Evans, S. J. W., et al. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology Neurosurgery and Psychiatry, 84(10), 1156–1160. CrossRef Evans, S. J. W., et al. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology Neurosurgery and Psychiatry, 84(10), 1156–1160. CrossRef
5.
go back to reference Paulsen, J. S. Early Detection of Huntington Disease. Future Neurology, 2010. 5(1), 85–104. CrossRef Paulsen, J. S. Early Detection of Huntington Disease. Future Neurology, 2010. 5(1), 85–104. CrossRef
7.
go back to reference Ross, C. A., et al. (1997). Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltimore), 76(5), 305–338. CrossRef Ross, C. A., et al. (1997). Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltimore), 76(5), 305–338. CrossRef
8.
go back to reference Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in oncology, 22(2 Suppl 3), 73–81. PubMed Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in oncology, 22(2 Suppl 3), 73–81. PubMed
9.
go back to reference Basch, E. (2010). The missing voice of patients in drug-safety reporting. New England Journal of Medicine, 362(10), 865–869. CrossRefPubMed Basch, E. (2010). The missing voice of patients in drug-safety reporting. New England Journal of Medicine, 362(10), 865–869. CrossRefPubMed
10.
go back to reference Carlozzi, N. E., et al. (2016). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research, 25(10), 2441–2455. CrossRefPubMedPubMedCentral Carlozzi, N. E., et al. (2016). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research, 25(10), 2441–2455. CrossRefPubMedPubMedCentral
11.
go back to reference Cella, D. F., et al. (2011). The Neurology Quality of Life Measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, Supplement., 92(Suppl 1), S28-S36. Cella, D. F., et al. (2011). The Neurology Quality of Life Measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, Supplement., 92(Suppl 1), S28-S36.
12.
go back to reference Cella, D., et al. (2012). Neuro-QOL brief measures of health-related quality of life for clinical research in neurology. Neurology, 78(23), 1860–1867. CrossRefPubMedPubMedCentral Cella, D., et al. (2012). Neuro-QOL brief measures of health-related quality of life for clinical research in neurology. Neurology, 78(23), 1860–1867. CrossRefPubMedPubMedCentral
13.
go back to reference Cella, D. F., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested in its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63, 1179–1194. CrossRefPubMedPubMedCentral Cella, D. F., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested in its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63, 1179–1194. CrossRefPubMedPubMedCentral
14.
go back to reference Cella, D. F., et al. (2007). The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Medical Care, 45(5 Suppl 1), S3–S11. Cella, D. F., et al. (2007). The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Medical Care, 45(5 Suppl 1), S3–S11.
15.
go back to reference Carlozzi, N. E., et al.(2016). The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea. Quality of Life Research, 25(20), 2429–2439. Carlozzi, N. E., et al.(2016). The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea. Quality of Life Research, 25(20), 2429–2439.
16.
go back to reference Carlozzi, N. E., et al. (2016). HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Quality of Life Research, 25(10), 2417–2427. Carlozzi, N. E., et al. (2016). HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Quality of Life Research, 25(10), 2417–2427.
17.
go back to reference Carlozzi, N. E., et al.(2016). New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system). Quality of Life Research, 25(10), 2403–2415. Carlozzi, N. E., et al.(2016). New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system). Quality of Life Research, 25(10), 2403–2415.
18.
go back to reference Tabrizi, S. J., et al. (2011). Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurology, 10(1), 31–42. CrossRefPubMed Tabrizi, S. J., et al. (2011). Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurology, 10(1), 31–42. CrossRefPubMed
19.
go back to reference Tabrizi, S. J., et al. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurology, 8(9), 791–801. CrossRefPubMedPubMedCentral Tabrizi, S. J., et al. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurology, 8(9), 791–801. CrossRefPubMedPubMedCentral
20.
go back to reference Paulsen, J. S., et al. (2014). Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study. Frontiers in Aging Neuroscience, 6, 78. CrossRefPubMedPubMedCentral Paulsen, J. S., et al. (2014). Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study. Frontiers in Aging Neuroscience, 6, 78. CrossRefPubMedPubMedCentral
21.
go back to reference Paulsen, J. S., et al. (2001). Clinical markers of early disease in persons near onset of Huntington’s disease. Neurology, 57(4), 658–662. CrossRefPubMed Paulsen, J. S., et al. (2001). Clinical markers of early disease in persons near onset of Huntington’s disease. Neurology, 57(4), 658–662. CrossRefPubMed
22.
go back to reference Peavy, G. M., et al. (2010). Cognitive and functional decline in Huntington’s disease: dementia criteria revisited. Movement Disorders, 25(9), 1163–1169. CrossRefPubMedPubMedCentral Peavy, G. M., et al. (2010). Cognitive and functional decline in Huntington’s disease: dementia criteria revisited. Movement Disorders, 25(9), 1163–1169. CrossRefPubMedPubMedCentral
23.
go back to reference Beglinger, L. J., et al. (2010). Cognitive change in patients with Huntington disease on the repeatable battery for the assessment of neuropsychological status. J Clin Exp Neuropsychol, 32(6), 573–578. CrossRefPubMed Beglinger, L. J., et al. (2010). Cognitive change in patients with Huntington disease on the repeatable battery for the assessment of neuropsychological status. J Clin Exp Neuropsychol, 32(6), 573–578. CrossRefPubMed
24.
go back to reference Stout, J. C., et al. (2012). Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. Journal of Neurology Neurosurgery Psychiatry, 12(7), 687–694. CrossRef Stout, J. C., et al. (2012). Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. Journal of Neurology Neurosurgery Psychiatry, 12(7), 687–694. CrossRef
25.
go back to reference Williams, J. K., et al. (2015). Everyday cognition in prodromal Huntington disease. Neuropsychology, 29(2), 255–267. CrossRefPubMed Williams, J. K., et al. (2015). Everyday cognition in prodromal Huntington disease. Neuropsychology, 29(2), 255–267. CrossRefPubMed
26.
go back to reference Ward, J., et al. (2006). A four-year prospective study of cognitive functioning in Huntington’s disease. Journal of the International Neuropsychological Society, 12(4), 445–454. CrossRefPubMed Ward, J., et al. (2006). A four-year prospective study of cognitive functioning in Huntington’s disease. Journal of the International Neuropsychological Society, 12(4), 445–454. CrossRefPubMed
28.
go back to reference Tabrizi, S. J., et al. (2012). Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurology, 11(1), 42–53. CrossRefPubMed Tabrizi, S. J., et al. (2012). Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurology, 11(1), 42–53. CrossRefPubMed
29.
go back to reference Ho, A. K., et al. (2003). Profile of cognitive progression in early Huntington’s disease. Neurology, 61(12), 1702–1706. CrossRefPubMed Ho, A. K., et al. (2003). Profile of cognitive progression in early Huntington’s disease. Neurology, 61(12), 1702–1706. CrossRefPubMed
30.
go back to reference Kirkwood, S. C., et al. (2001). Progression of symptoms in the early and middle stages of Huntington disease. Archives of Neurology, 58(2), 273–278. CrossRefPubMed Kirkwood, S. C., et al. (2001). Progression of symptoms in the early and middle stages of Huntington disease. Archives of Neurology, 58(2), 273–278. CrossRefPubMed
31.
go back to reference Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20(1), 10. CrossRef Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20(1), 10. CrossRef
32.
go back to reference Paulsen, J. S., et al. (2008). Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880. CrossRef Paulsen, J. S., et al. (2008). Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880. CrossRef
33.
go back to reference Hanauer, D. A., et al. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300. CrossRefPubMedPubMedCentral Hanauer, D. A., et al. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300. CrossRefPubMedPubMedCentral
34.
go back to reference Jackson, W., & TA, N. (1998). Effective serial measurement of cognitive orientation in rehabilitation: the Orientation Log. Archives of Physical Medicine and Rehabilitation, 79(6), 718–720. CrossRefPubMed Jackson, W., & TA, N. (1998). Effective serial measurement of cognitive orientation in rehabilitation: the Orientation Log. Archives of Physical Medicine and Rehabilitation, 79(6), 718–720. CrossRefPubMed
35.
go back to reference Huntington Study Group, (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11(2): 136–142. CrossRef Huntington Study Group, (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11(2): 136–142. CrossRef
36.
go back to reference Shoulson, I., & Fahn, S. (1979). Huntington disease clinical care and evaluation. Neurology, 29(1), 1–1. CrossRefPubMed Shoulson, I., & Fahn, S. (1979). Huntington disease clinical care and evaluation. Neurology, 29(1), 1–1. CrossRefPubMed
37.
go back to reference Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, Vol 18, Pg 643–662, 1935). Journal of Experimental Psychology: General, 121(1), 15. CrossRef Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, Vol 18, Pg 643–662, 1935). Journal of Experimental Psychology: General, 121(1), 15. CrossRef
38.
go back to reference Marder, K., et al. (2000). Rate of functional decline in Huntington’s disease. Neurology, 54(2), 452–452. CrossRefPubMed Marder, K., et al. (2000). Rate of functional decline in Huntington’s disease. Neurology, 54(2), 452–452. CrossRefPubMed
39.
go back to reference Smith, A. (1995). Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services. Smith, A. (1995). Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services.
40.
go back to reference Crane, P. K., et al. (2006). Differential item functioning analysis with ordinal logistic regression techniques. DIFdetect and difwithpar. Medical Care, 44(11 Suppl 3), S115-S123. Crane, P. K., et al. (2006). Differential item functioning analysis with ordinal logistic regression techniques. DIFdetect and difwithpar. Medical Care, 44(11 Suppl 3), S115-S123.
41.
go back to reference Choi, S. W., Gibbons, L. E., & Crane, P. K. (2011). Lordif: An R package for detecting differential item functioning using iterative hybrid ordinal logistic regression/item response theory and monte carlo simulations. Journal of Statistical Software, 39(8), 1–30. CrossRefPubMedPubMedCentral Choi, S. W., Gibbons, L. E., & Crane, P. K. (2011). Lordif: An R package for detecting differential item functioning using iterative hybrid ordinal logistic regression/item response theory and monte carlo simulations. Journal of Statistical Software, 39(8), 1–30. CrossRefPubMedPubMedCentral
42.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences ( 2nd edition). New York: Academic Press. Cohen, J. (1988). Statistical power analysis for the behavioral sciences ( 2nd edition). New York: Academic Press.
43.
go back to reference DeVellis, R. (2017) Scale development: Theory and applications. In L. Bickman & D. J. Rog (Eds.) Applied social research methods series, 4th edn. Los Angeles: Sage. DeVellis, R. (2017) Scale development: Theory and applications. In L. Bickman & D. J. Rog (Eds.) Applied social research methods series, 4th edn. Los Angeles: Sage.
44.
go back to reference Heemskerk, A. W., & Roos, R. A. (2011). Dysphagia in Huntington’s disease: A review. Dysphagia, 26(1), 62–66. CrossRefPubMed Heemskerk, A. W., & Roos, R. A. (2011). Dysphagia in Huntington’s disease: A review. Dysphagia, 26(1), 62–66. CrossRefPubMed
45.
go back to reference Kagel, M. C., & Leopold, N. A. (1992). Dysphagia in Huntington’s disease: A 16-year retrospective. Dysphagia, 7(2), 106–114. CrossRefPubMed Kagel, M. C., & Leopold, N. A. (1992). Dysphagia in Huntington’s disease: A 16-year retrospective. Dysphagia, 7(2), 106–114. CrossRefPubMed
46.
go back to reference Reilmann, R., Leavitt, B. R., & Ross, C. A. (2014). Diagnostic criteria for Huntington’s disease based on natural history. Movement Disorders, 29(11), 1335–1341. CrossRefPubMed Reilmann, R., Leavitt, B. R., & Ross, C. A. (2014). Diagnostic criteria for Huntington’s disease based on natural history. Movement Disorders, 29(11), 1335–1341. CrossRefPubMed
47.
go back to reference Ross, C. A., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews. Neurology, 10, 204–216. CrossRefPubMed Ross, C. A., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews. Neurology, 10, 204–216. CrossRefPubMed
48.
go back to reference Dorsey, E. R., et al. (2013). Natural history of Huntington disease. JAMA Neurol, 70(12), 1520–1530. PubMed Dorsey, E. R., et al. (2013). Natural history of Huntington disease. JAMA Neurol, 70(12), 1520–1530. PubMed
49.
go back to reference Pagan, F., Torres-Yaghi, Y., & Altshuler, M. (2017). The diagnosis and natural history of Huntington disease. Handbook of Clinical Neurology, 144, 63–67. CrossRefPubMed Pagan, F., Torres-Yaghi, Y., & Altshuler, M. (2017). The diagnosis and natural history of Huntington disease. Handbook of Clinical Neurology, 144, 63–67. CrossRefPubMed
50.
go back to reference McCusker, E., & Loy, C. T. (2014). The many facets of unawareness in Huntington disease. Tremor Other Hyperkinet Mov (N Y), 4, 257. McCusker, E., & Loy, C. T. (2014). The many facets of unawareness in Huntington disease. Tremor Other Hyperkinet Mov (N Y), 4, 257.
51.
go back to reference Deckel, A. W., & Morrison, D. (1996). Evidence of a neurologically based “denial of illness” in patients with Huntington’s disease. Archives of Clinical Neuropsychology, 11(4), 295–302. CrossRefPubMed Deckel, A. W., & Morrison, D. (1996). Evidence of a neurologically based “denial of illness” in patients with Huntington’s disease. Archives of Clinical Neuropsychology, 11(4), 295–302. CrossRefPubMed
52.
go back to reference Vitale, C., et al. (2001). Unawareness of dyskinesias in Parkinson’s and Huntington’s diseases. Neurological Sciences, 22(1), 105–106. CrossRefPubMed Vitale, C., et al. (2001). Unawareness of dyskinesias in Parkinson’s and Huntington’s diseases. Neurological Sciences, 22(1), 105–106. CrossRefPubMed
53.
go back to reference Chatterjee, A., et al. (2005). A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 17(3), 378–383. CrossRefPubMed Chatterjee, A., et al. (2005). A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 17(3), 378–383. CrossRefPubMed
54.
go back to reference Duff, K., et al. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: evidence of early lack of awareness. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207. CrossRefPubMedPubMedCentral Duff, K., et al. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: evidence of early lack of awareness. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207. CrossRefPubMedPubMedCentral
55.
go back to reference Pringsheim, T., et al. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091. CrossRefPubMed Pringsheim, T., et al. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091. CrossRefPubMed
56.
go back to reference Folstein, S. E..(1989). Huntington’s disease: A disorder of families. Baltimore :Johns Hopkins University Press. Folstein, S. E..(1989). Huntington’s disease: A disorder of families. Baltimore :Johns Hopkins University Press.
57.
go back to reference Hayden, M. R., MacGregor, J. M., & Beighton, P. H. (1980). The prevalence of Huntington’s chorea in South Africa. South African Medical Journal, 58, 193–196. PubMed Hayden, M. R., MacGregor, J. M., & Beighton, P. H. (1980). The prevalence of Huntington’s chorea in South Africa. South African Medical Journal, 58, 193–196. PubMed
58.
go back to reference Narabayashi, H. (1973). Huntington’s chorea in Japan: Review of the literature. Advances in neurology, 1, 253–259. Narabayashi, H. (1973). Huntington’s chorea in Japan: Review of the literature. Advances in neurology, 1, 253–259.
Metagegevens
Titel
Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?
Auteurs
N. E. Carlozzi
S. Schilling
A. L. Kratz
J. S. Paulsen
S. Frank
J. C. Stout
Publicatiedatum
16-06-2018
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1912-6